beta

GILD

Gilead Sciences, Inc.

Gild

Chart

Stats

Earnings

News

Splits

Dividends

Earnings

Actual EPS
Consensus EPS
Estimated EPS
Number of Estimates
EPS Surprise

Stats

Summary

Gilead Sciences, Inc. is a biopharmaceutical company, which engages in the research, development, and commercialization of medicines in areas of unmet medical need. Its primary areas of focus include human immunodeficiency virus, acquired immunodeficiency syndrome, liver diseases, hematology, oncology, and inflammation and respiratory diseases. It offers antiviral products under Harvoni, Genvoya, Epclusa, Truvada, Atripla, Descovy, Stribild, Viread, Odefsey, Complera/Eviplera, Sovaldi, and Vosevi brands. The company was founded by Michael L. Riordan on June 22, 1987 and is headquartered in Foster City, CA.

Market Cap: 81.8 Billion

Primary Exchange: NASDAQ

Website: http://www.gilead.com

Shares Outstanding: 1.27 Billion

Float: 1.26 Billion

Dividend: 2.46 (0.04%)

Beta: 0.793798310192539

Sector: Health Technology

Industry: Biotechnology

Short Interest (Jan 12, 2018): 21.8 Million

Ethical Flags

Animal testing

Longest drawdown: 1278 trading days

From: 2015-06-23 To: 2019-11-12

Lowest Point:

Akero Therapeutics Readies $75 Million IPO

via: SeekingAlpha at 2019-06-13 09:11:26:000

Quick Take Akero Therapeutics ( AKRO ) has filed to raise gross proceeds of $75.0 million from a U.S. IPO, according to an S-1/A registration statement . The firm is developing a treatment for metabolic diseases with high unmet clinical needs, with an initial focus on non-alcoholic steato… read more...

June 2019 Stock Considerations

via: SeekingAlpha at 2019-06-12 23:24:27:000

After a wild May we seem to be trending back up in June. Of course, anyone in the DGI space already knows that these daily, weekly and monthly swings really don't matter to anyone with a very long-term time horizon. All we can do in the meantime is watch the market swing, stay in the game, fin… read more...

BIIB Is For Buy-O-Gen

via: SeekingAlpha at 2019-06-12 06:30:36:000

Let's spell Biogen Buy-o-Gen. Indeed, BIIB seems increasingly appealing at current price. The biotech focuses on discovering, developing, and delivering therapies to people living with serious neurological, rare and autoimmune diseases. The Company markets various products for multiple sc… read more...

Gilead Hopes To Continue Sales Expansion Of Yescarta - Results From KTE-X19 Step In The Right Direction

via: SeekingAlpha at 2019-06-11 13:29:35:000

Gilead Sciences ( GILD ) reported final results from its phase 1 study using its CAR-T cell therapy KTE-X19 to treat patients with relapsed/refractory acute lymphoblastic leukemia ((ALL)). This was early clinical data that was presented at the American Society for Clinical Oncology ((ASCO)) … read more...

How To Find Undervalued Stocks In The Healthcare Sector

via: SeekingAlpha at 2019-06-10 12:10:41:000

The healthcare sector is underperforming the market by a wide margin on a year to date basis. The Healthcare Select Sector ETF ( XLV ) has gained 5.2%, while the SPDR S&P 500 ( SPY ) is up by almost three times that, with a cumulative gain of 15.1% in the same period. Data by YCharts … read more...

Dividend Challenger Highlights: Week Of June 9

via: SeekingAlpha at 2019-06-10 02:40:50:000

Introduction The Dividend Champions list is a monthly compilation of companies which have consistently increased their annual dividend payouts, and the latest edition may be found here . However, since this list is only produced once per month, the data in it can quickly get out of date. Fu… read more...

Ex-Date Payment Date Record Date Declared Date Amount Flag Dividend Type Qualified Indicated
2019-12-12 2019-12-30 2019-12-13 2019-10-23 0.63 Cash
2019-09-12 2019-09-27 2019-09-13 2019-07-30 0.63 No Change QoQ
2019-06-13 2019-06-27 2019-06-14 2019-05-02 0.63 No Change QoQ
2019-03-14 2019-03-28 2019-03-15 2019-02-04 0.63 Increase
2018-12-13 2018-12-28 2018-12-14 2018-10-25 0.57 No Change QoQ
2018-09-13 2018-09-27 2018-09-14 2018-07-25 0.57 No Change QoQ
2018-06-14 2018-06-28 2018-06-15 2018-05-01 0.57 No Change QoQ
2018-03-15 2018-03-29 2018-03-16 2018-02-06 0.57 Increase
2017-12-14 2017-12-28 2017-12-15 2017-10-26 0.52 No Change QoQ
2017-09-14 2017-09-28 2017-09-15 2017-07-26 0.52 No Change QoQ
2017-06-14 2017-06-29 2017-06-16 2017-05-02 0.52 No Change QoQ
2017-03-14 2017-03-30 2017-03-16 2017-02-07 0.52 Increase
2016-12-13 2016-12-29 2016-12-15 2016-11-01 0.47 No Change QoQ
2016-09-14 2016-09-29 2016-09-16 2016-07-25 0.47 No Change QoQ
2016-06-14 2016-06-29 2016-06-16 2016-04-28 0.47 Increase
2016-03-14 2016-03-30 2016-03-16 2016-02-02 0.43 No Change QoQ
2015-12-14 2015-12-30 2015-12-16 2015-10-27 0.43 No Change QoQ
2015-09-14 2015-09-29 2015-09-16 2015-07-28 0.43 No Change QoQ
2015-06-12 2015-06-29 2015-06-16 2015-04-30 0.43 No Change QoQ
Ex-Date Declared Date Record Date Payment Date Ratio To Factor For Factor
2013-01-28 2012-12-10 2013-01-07 2013-01-25 00:00:00 -0500 0.5 2.0 1.0
Data provided by IEX Cloud